Podcasts / Public fertility care awareness for healthcare professionals
Save
0.5 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0.5 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.
Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.
In this episode:
Experts: A/Prof Kate Stern, Fertility Specialist, Gynaecologist and Reproductive Endocrinologist
A/Prof Wan Tinn Teh, Gynaecologist and Fertility Specialist
Host: Dr Terri Foran, GP and Medical Educator
Total time: 28 mins
Recommended resources:
Menopause and MHT: Maximising Benefits & Minimising Risks
Multiple Sclerosis vs Antibody Disease – What GPs Need to Know
Using SGLT2 to Reduce Cardiovascular Death in T2D – Important Updates for GPs
Peripheral Arterial Disease
expert
Fertility Specialist, Gynaecologist and Reproductive Endocrinologist, University of Melbourne, Royal Women’s Hospital; Head, Endocrine and Metabolic Service and Acting Head of Reproductive Services, Royal Women’s Hospital Melbourne, Clinical Director and Head, Clinical Research at Melbourne IVF
expert
Gynaecologist and Fertility Specialist; City Fertility and Epworth Healthcare (Freemason and Eastern); Co-medical director, Public Fertility Services, Royal Women’s Hospital
Browse the latest podcasts from Healthed.
You have completed the Educational Activities (EA) component of this activity.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease